Brain Navi Biotechnology
About Brain Navi Biotechnology
Brain Navi Biotechnology is a leading Taiwanese surgical robotics company that specializes in developing innovative navigation and robotic techniques for neurosurgery. Their flagship product, NaoTrac, is an autonomous neurosurgical navigation robot designed to enhance surgical precision, efficiency, and accessibility. NaoTrac utilizes Brain Navi’s patented SMART (Surface Mapping Auto-registration Technology) platform, which integrates machine vision, AI technology, and a robotic arm to provide real-time imaging, precise surgical guidance, and minimally invasive outcomes.
For physicians, NaoTrac offers several key advantages. It supports various medical imaging modalities (CT and MRI) and is applicable to procedures such as brain tumor biopsy, deep brain stimulation (DBS), stereotactic electroencephalography (SEEG), endoscopic surgery, and external ventricular drain (EVD) placements. The system features fast and precise navigation with non-contact registration, pre-operative planning, and 3D vision for accurate anatomical location. Its unique autonomous procedure allows surgeons to plan the operation while NaoTrac acts as an assistant, precisely inserting instruments into the target lesion. NaoTrac’s patient registration process uses over 100,000 checkpoints, increasing accuracy to less than 0.5mm, and its AI technology facilitates intuitive facial recognition for flexible surgical positioning, including prone positions. The system also offers non-contact movement detection, recalibrating if the surgical bed moves incidentally. NaoTrac has received CE Mark, Taiwan FDA, and U.S. FDA 510(k) clearances, and has been adopted by hospitals internationally.
Focus Areas
Business Intelligence
| Key Investors | Kyber Capital, Sunsino Venture Group, RAPID-Health, Midana Capital |
| Partnerships | BenQ Medical Technology, Palex Healthcare, Medtreq Medical Equipment, Hualien Tzu-Chi Medical Center, Avalue Healthcare, First Securities Inc. |
| Technology | SMART (Surface Mapping Auto-registration Technology) platform, machine vision, AI algorithms, robotic technology, cloud-native (implied through AI and real-time data processing) |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Brain Navi's NaoTrac offers enhanced precision and efficiency in neurosurgery, potentially reducing surgical time and improving patient outcomes. The autonomous navigation and non-contact registration simplify the surgical workflow and shorten the learning curve for new users. The compatibility with standard surgical instruments allows surgeons to utilize tools they are already familiar with. The real-time imaging and 3D visualization capabilities provide superior guidance and planning. Furthermore, the system's ability to operate in various patient positions, including prone, offers greater flexibility in the operating room. The KrystoLens disposable endoscope also addresses concerns about infection control and workflow efficiency.
Brain Navi's NaoTrac supports various medical imaging modalities, including CT and MRI, for comprehensive surgical planning. The system's architecture, as seen with its collaboration with Avalue Healthcare, utilizes high-performance computing and AI PCs for real-time AI processing and reliable operation, suggesting potential for integration with advanced hardware platforms. The open approach to surgical tool recognition also implies a degree of flexibility for integration with existing surgical instrument sets.
What the Web Says
Brain Navi Biotechnology is a Taiwanese company specializing in neurosurgical navigation robots. Their flagship product, NaoTrac, utilizes AI, machine vision, and robotic-assisted surgery to enhance precision and streamline procedures. The company has received positive feedback from surgeons regarding the robot's accuracy, ability to reduce surgical time, and potential to improve patient outcomes and recovery. Brain Navi has obtained regulatory approvals including CE Mark, Taiwan FDA, and U.S. FDA clearance for NaoTrac. While product reviews are generally positive, there is limited information available on employer reviews from major platforms like Glassdoor or Capterra specifically for Brain Navi Biotechnology.
Overall: PositiveStrengths
- NaoTrac significantly improves surgical accuracy (1-2mm deviation).
- Reduces anesthesia and surgical time.
- Streamlines surgical procedures and shortens the learning curve for surgeons.
- Enhances patient well-being through less invasive interventions and faster recovery.
- Utilizes advanced AI, machine vision, and robotic-assisted surgery with non-contact registration.
- Versatile for various neurosurgical procedures including biopsies, tumor ablations, and EVD placements.
Limitations
- Limited publicly available employer reviews on major platforms.
- Some general reviews on platforms like G2 and Capterra (not specific to Brain Navi) mention initial fine-tuning for advanced workflows or being less beginner-friendly for complex software.
Based on reviews from: BioWorld, Brain Navi, PR Newswire, healthcare-in-europe.com, BioSpace, Indeed.com, G2, Capterra
Last updated: 2026-07-02
Videos
News, demos, and interviews about Brain Navi Biotechnology.
Videos load interactively. If none appear, search YouTube for Brain Navi Biotechnology →
Frequently Asked Questions
Investors
Who's funded Brain Navi Biotechnology.
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]